The Outcomes of Percutaneous RevascularizaTIon for Management of SUrgically Ineligible Patients With Multivessel or Left Main Coronary Artery Disease (OPTIMUM) Registry: Rationale and Design
- 31 January 2022
- journal article
- research article
- Published by Elsevier in Cardiovascular Revascularization Medicine
- Vol. 41, 83-91
Abstract
No abstract availableKeywords
Funding Information
- Boston Scientific Corporation (ISROTH10299)
- Abbott Vascular
- Cardiovascular Systems
- Biotronik
- Medtronic
This publication has 38 references indexed in Scilit:
- ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 Appropriate Use Criteria for Coronary Revascularization Focused UpdateJACC, 2012
- Surgical Candidacy and Selection Biases in Nonemergent Left Main StentingJACC: Cardiovascular Interventions, 2011
- Standardized Bleeding Definitions for Cardiovascular Clinical TrialsCirculation, 2011
- Predicting Successful Guidewire Crossing Through Chronic Total Occlusion of Native Coronary Lesions Within 30 MinutesJACC: Cardiovascular Interventions, 2011
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- US Valuation of the EQ-5D Health StatesMedical Care, 2005
- EQ-SD: a measure of health status from the EuroQol GroupAnnals of Medicine, 2001
- A Multicenter, Randomized Trial of Percutaneous Coronary Intervention Versus Bypass Surgery in High-Risk Unstable Angina PatientsControlled Clinical Trials, 1999
- Monitoring the quality of life in patients with coronary artery diseaseThe American Journal of Cardiology, 1994
- Prognostic value of a coronary artery jeopardy scoreJACC, 1985